These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28078747)

  • 1. Granulocyte-Monocyte Apheresis as an Adjuvant Therapy to Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis.
    Rodríguez-Lago I; Gómez-Irwin L; Fernández E; Higuera R; Cabriada JL
    Ther Apher Dial; 2017 Feb; 21(1):26-30. PubMed ID: 28078747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis.
    Rodríguez-Lago I; Sempere L; Gutiérrez A; Núñez A; Leo Carnerero E; Hinojosa E; Mora M; Cañete F; Mañosa M; Herrera C; Beltrán B; Forés A; Arjona D; Barreiro-de Acosta M; Khorrami S; Aguirre U; Ginard D; Cabriada JL
    Scand J Gastroenterol; 2019 Apr; 54(4):459-464. PubMed ID: 30982369
    [No Abstract]   [Full Text] [Related]  

  • 3. The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?
    Rodríguez-Lago I; Benítez JM; Sempere L; Sáez-González E; Barreiro-de Acosta M; de Zárate JO; Cabriada JL
    J Clin Apher; 2019 Dec; 34(6):680-685. PubMed ID: 31518013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective granulocyte-monocyte apheresis during induction with vedolizumab in moderate-severe ulcerative colitis: Experience in a tertiary hospital.
    Suárez Ferrer C; Martin-Arranz E; Martín-Arranz MD
    Gastroenterol Hepatol; 2024; 47(7):721-726. PubMed ID: 38219961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
    Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis.
    Yoshino T; Nakase H; Minami N; Yamada S; Matsuura M; Yazumi S; Chiba T
    Dig Liver Dis; 2014 Mar; 46(3):219-26. PubMed ID: 24268950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum associated with ulcerative colitis: A recalcitrant case responded to adalimumab with granulocyte and monocyte adsorption apheresis.
    Isami Y; Kawase Y; Kondo A; Akita W; Yasuda K; Matsutani T; Mitsui H
    J Dermatol; 2020 May; 47(5):e213-e215. PubMed ID: 32162361
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitis.
    Nakamura T; Kawagoe Y; Matsuda T; Ueda A; Ueda Y; Takahashi Y; Tanaka A; Koide H
    Blood Purif; 2004; 22(6):499-504. PubMed ID: 15528877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA and granulocyte-monocyte adsorption apheresis combotherapy after inadequate response to anti-TNF agents in ulcerative colitis.
    Sáez-González E; Moret-Tatay I; Bastida G; Aguas M; Iborra M; Nos P; Beltrán B
    J Clin Apher; 2024 Feb; 39(1):e22101. PubMed ID: 38054256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy.
    Sagawa T; Kakizaki S; Tomizawa T; Nakayama T; Tanaka H; Tojima H; Sato K; Kusano M; Okamura S; Yamada M
    Colorectal Dis; 2016 Jul; 18(7):696-702. PubMed ID: 26748553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease.
    Edfors K; Ståhlberg D; Söderman C
    Ther Apher Dial; 2016 Feb; 20(1):79-85. PubMed ID: 26841133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study to investigate the efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with primary sclerosing cholangitis with ulcerative colitis.
    Ito A; Murasugi S; Yonezawa M; Omori T; Nakamura S; Tokushige K
    J Clin Apher; 2024 Feb; 39(1):e22099. PubMed ID: 37990778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New-Onset Inflammatory Bowel Colitis.
    Rolandsdotter H; Eberhardson M; Fagerberg UL; Finkel Y
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):84-89. PubMed ID: 28604509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocytes and monocytes apheresis induces upregulation of TGFβ
    Contini P; Negrini S; Bodini G; Trucchi C; Ubezio G; Strada P; Savarino V; Ghio M
    J Clin Apher; 2017 Feb; 32(1):49-55. PubMed ID: 27080173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
    Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
    Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of a Case of Ulcerative Colitis with Sacroiliitis Using Granulocyte and Monocyte Adsorption Apheresis.
    Ichikawa H; Imai J; Mizukami H; Shirai T; Watanabe N
    Tokai J Exp Clin Med; 2017 Jul; 42(2):64-66. PubMed ID: 28681364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
    Suzuki Y; Yoshimura N; Fukuda K; Shirai K; Saito Y; Saniabadi AR
    Dig Dis Sci; 2006 Nov; 51(11):2031-8. PubMed ID: 17004123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.